1[1]Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the framingham study[J].Stroke,1991,22 (8):983-988.
2[2]Atrial fibrillation investigator:Risk factors for stroke and efficacy of antithrombotic therapy an atrial fibril-lation.analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154:1449-1457.
3[3]Go AS,Hylek EM,Philips JA,et al.Prevalence of diagnosed atrial fibrillation in adults;national implications for rhythm management and stroke prevention; the anticoagula-tion and risk factors in atrial fibrillation(ATRIA) study[J].JAMA,2001,285(18):2370-2375.
4[4]Stroke Prevention in Atrial Fibrillation Investigators.Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation:the stroke prevention in atrial fibrillation study[J].J Stroke Cerebrovasc Dis,1995,5:147-157.
5[5]Gage BF,Waterman AD,Shannon W,et al.Validation of clinical classification schemes for predicting stroke:results from the national registry of atrial fibrillation[J].JAMA,2001,285 (22):2864-2870.
6[6]Petersen P,Boysen G,Godtfredsen J,et al.Place-controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.The Copenhagen AFASAK study[J].lancet,1989,1 ;175-179.
7[7]Stroke prevention in atrial fibrillation investigators:Stroke prevention in atrial fibrillation study final results[J].Circulation,1991,84(2):527-539.
8[8]The Bosten Area Anticoagulation Trial for Atrial Fibrillation Investigators.The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation[J].N Engl J Med,1990,323(22):1505-1511.
9[9]Ezekowitz MD,Bridgers SL,James KE,et al.Wafarin in the prevention of stroke associated with nonrheumatic atrial fibrillation[J].N Engl J Med,1992,327(20):1406-1412.
